Structures by: Nagaraja P.
Total: 20
2-benzoyloxy-5-methylbenzophenone
C21H16O3
Acta Crystallographica Section E (2004) 60, 10 o1889-o1891
a=9.2068(5)Å b=9.7961(5)Å c=10.1375(6)Å
α=94.732(4)° β=112.570(5)° γ=102.194(4)°
Morpholinoethyl 6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)- 4-methylhex-4-enoate
C23H31NO7
Acta Crystallographica Section E (2004) 60, 12 o2223-o2224
a=20.784(2)Å b=9.3210(6)Å c=11.9373(11)Å
α=90.00° β=106.719(7)° γ=90.00°
6-fluoro-3-(4-piperidinio)benz[d]isoxazole chloride
C12H14FN2O,Cl
Acta Crystallographica Section E (2005) 61, 2 o356-o358
a=13.020(6)Å b=6.608(3)Å c=15.119(7)Å
α=90.00° β=113.109(7)° γ=90.00°
10-Methoxydibenz[b,f]azepine-5-carboxamide
C16H14N2O2
Acta Crystallographica Section E (2005) 61, 6 o1760-o1761
a=8.8003(2)Å b=9.2012(2)Å c=9.3735(3)Å
α=64.6999(16)° β=76.0520(15)° γ=83.7398(18)°
Sildenafil citrate monohydrate
C22H31N6O4S,C6H7O7,H2O
Acta Crystallographica Section E (2005) 61, 2 o489-o491
a=24.002(4)Å b=10.9833(17)Å c=24.364(3)Å
α=90.00° β=90.00° γ=90.00°
6,6,8a-Trimethyl-3a,6,7,8a-tetrahydrobenzo[b]furo[3,2-d]furan-2,4(3H,5H)-dione
C13H16O4
Acta Crystallographica Section E (2005) 61, 4 o1041-o1042
a=9.4853(3)Å b=10.2904(2)Å c=12.2872(4)Å
α=90.00° β=90.00° γ=90.00°
Thionordazepam
C15H11Cl1N2S1
Acta Crystallographica Section E (2005) 61, 9 o2934-o2936
a=9.993(2)Å b=14.223(3)Å c=10.175(2)Å
α=90.00° β=90.00° γ=90.00°
(2-Chloroanilino)acetophenone
C14H12ClNO
Acta Crystallographica Section E (2005) 61, 8 o2551-o2552
a=18.363(4)Å b=5.2852(14)Å c=12.509(2)Å
α=90.00° β=90.00° γ=90.00°
1-(4-Fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
C15H10FNO
Acta Crystallographica Section E (2004) 60, 12 o2225-o2227
a=14.606(2)Å b=5.8056(6)Å c=27.037(4)Å
α=90.00° β=99.032(11)° γ=90.00°
2,2'-dinitrodibenzyl
C14H12N2O4
Acta Crystallographica Section E (2004) 60, 12 o2455-o2456
a=7.5678(8)Å b=14.4964(16)Å c=5.9874(5)Å
α=90.00° β=108.607(6)° γ=90.00°
2-methyl-1-(1,2,3,9-tetrahydro-9-methyl-4-oxo-4H-carbazol-3-ylmethyl)-1H- imidazol-3-ium chloride dihydrate
C18H20N3O,Cl,2H2O
Acta Crystallographica Section E (2005) 61, 1 o47-o48
a=15.0216(13)Å b=9.6464(8)Å c=12.6545(10)Å
α=90.00° β=100.708(6)° γ=90.00°
Pioglitazone hydrochloride
C19H21N2O3S,Cl
Acta Crystallographica Section E (2005) 61, 1 o154-o155
a=10.0696(17)Å b=9.4318(16)Å c=10.1752(19)Å
α=90.00° β=95.178(14)° γ=90.00°
4'-(2-Butyl-4-chloro-5-formylimidazol-1-ylmethyl)biphenyl-2-carbonitrile
C22H20ClN3O
Acta Crystallographica Section E (2005) 61, 4 o1193-o1195
a=8.9729(4)Å b=22.6232(9)Å c=9.9288(5)Å
α=90.00° β=106.427(4)° γ=90.00°
4-(2-Chloroethyl)morpholinium chloride
C6H13ClNO,Cl
Acta Crystallographica Section E (2005) 61, 4 o849-o850
a=6.9876(3)Å b=8.1549(4)Å c=8.6495(3)Å
α=63.530(2)° β=85.004(3)° γ=85.179(2)°
1-(Carbamoylmethyl)cyclohexanecarboxylic acid
C9H15NO3
Acta Crystallographica Section E (2005) 61, 4 o884-o885
a=13.4973(5)Å b=8.0905(2)Å c=8.8358(3)Å
α=90.00° β=102.627(2)° γ=90.00°
Desipraminium picrate monohydrate
C18H23N2,C6H2N3O7,H2O
Acta Crystallographica Section E (2007) 63, 9 o3892-o3892
a=10.3126(4)Å b=11.2594(5)Å c=11.4304(5)Å
α=72.1620(10)° β=79.2880(10)° γ=87.2330(10)°
Trityl losartan
C41H37ClN6O
Acta Crystallographica Section C (2004) 60, 11 o821-o823
a=8.6962(3)Å b=20.5493(6)Å c=21.7392(5)Å
α=69.597(2)° β=88.587(2)° γ=78.962(3)°
Nitrobenzene derivative
C7H7Cl2N2O2,Cl
Acta Crystallographica Section C (2006) 62, 1 o36-o38
a=6.889(7)Å b=12.116(12)Å c=13.286(13)Å
α=102.128(15)° β=100.939(16)° γ=103.523(16)°
2-butyl-4-chloro-1-(6-methyl-1,3-benzodioxol-5-ylmethyl)-1H-imidazole- 5-carboxaldehyde
C17H19ClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=12.4899(5)Å b=9.4887(3)Å c=14.1018(5)Å
α=90.00° β=94.3190(10)° γ=90.00°
1-(2-bromo-4,5-dimethoxybenzyl)-2-butyl-4-chloro-1H-imidazole-5-carboxaldehyde
C17H20BrClN2O3
Acta Crystallographica Section C (2005) 61, 3 o177-o180
a=8.547(2)Å b=10.308(2)Å c=10.611(2)Å
α=91.654(4)° β=100.667(4)° γ=93.623(3)°